LORD, ABBETT & CO. LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$8,817,000
-26.3%
176,761
-0.3%
0.03%
-27.5%
Q1 2019$11,961,000
+41.9%
177,353
-3.0%
0.04%
+29.0%
Q4 2018$8,430,000
-78.0%
182,828
-63.2%
0.03%
-70.8%
Q3 2018$38,327,000
-62.3%
496,973
-58.9%
0.11%
-64.3%
Q2 2018$101,757,000
+19.1%
1,208,083
+15.7%
0.30%
+16.9%
Q1 2018$85,407,000
+294.5%
1,044,346
+175.8%
0.25%
+309.7%
Q4 2017$21,648,000
-34.0%
378,662
-22.9%
0.06%
-35.4%
Q3 2017$32,788,000
+138.8%
491,203
+84.0%
0.10%
+134.1%
Q2 2017$13,733,000
+59.9%
266,910
+81.5%
0.04%
+57.7%
Q1 2017$8,589,000
+27.2%
147,074
-9.1%
0.03%
+23.8%
Q4 2016$6,753,000
-74.9%
161,836
-68.2%
0.02%
-74.4%
Q3 2016$26,857,000
+55.6%
508,469
+23.4%
0.08%
+51.9%
Q2 2016$17,257,000
+30.6%
411,920
+26.6%
0.05%
+28.6%
Q1 2016$13,215,000
+17.2%
325,497
+87.4%
0.04%
+23.5%
Q4 2015$11,278,000
+223.9%
173,722
+252.2%
0.03%
+209.1%
Q3 2015$3,482,000
-85.2%
49,321
-76.7%
0.01%
-82.3%
Q2 2015$23,536,000
+59.7%
211,773
+35.5%
0.06%
+67.6%
Q1 2015$14,740,000
-56.4%
156,308
-48.2%
0.04%
-57.0%
Q4 2014$33,782,000
-56.0%
301,517
-75.9%
0.09%
-55.4%
Q3 2014$76,798,000
-30.1%
1,251,795
-47.8%
0.19%
+54.4%
Q2 2014$109,826,000
+545.5%
2,396,880
+451.5%
0.12%
+220.5%
Q1 2014$17,015,000
+467.4%
434,616
+247.1%
0.04%
+457.1%
Q4 2013$2,999,000125,2000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders